Hereditary pyropoikilocytosis

From WikiMD's WELLNESSPEDIA

(Redirected from Pyropoikilocytosis)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Hereditary pyropoikilocytosis
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Hemolytic anemia, jaundice, splenomegaly, fatigue
Complications Gallstones, iron overload
Onset Infancy or early childhood
Duration Chronic
Types N/A
Causes Mutations in the spectrin gene
Risks Family history of the condition
Diagnosis Blood smear, complete blood count, genetic testing
Differential diagnosis Hereditary spherocytosis, hereditary elliptocytosis, pyruvate kinase deficiency
Prevention N/A
Treatment Blood transfusion, splenectomy, folic acid supplementation
Medication
Prognosis Variable, can be severe
Frequency Rare
Deaths


Hereditary Pyropoikilocytosis is a rare, inherited blood disorder characterized by anemia, abnormally shaped red blood cells, and an increased susceptibility to infection. This condition is a severe form of Hereditary Elliptocytosis and is caused by mutations in the SPTA1 or SPTB gene.

Symptoms[edit]

The symptoms of Hereditary Pyropoikilocytosis typically appear in infancy and can vary in severity. They may include:

  • Anemia - A condition in which the body does not have enough healthy red blood cells.
  • Jaundice - A yellowing of the skin and eyes.
  • Splenomegaly - An enlargement of the spleen.
  • Increased susceptibility to Infection - Due to the reduced number of healthy red blood cells.

Causes[edit]

Hereditary Pyropoikilocytosis is caused by mutations in the SPTA1 or SPTB gene. These genes provide instructions for making proteins that are part of the cytoskeleton of red blood cells. Mutations in these genes disrupt the structure of these cells, leading to the characteristic features of this disorder.

Diagnosis[edit]

Diagnosis of Hereditary Pyropoikilocytosis is based on a complete medical history, a physical examination, and specialized blood tests. These tests can reveal the characteristic abnormally shaped red blood cells of this disorder.

Treatment[edit]

Treatment for Hereditary Pyropoikilocytosis is aimed at managing the symptoms and preventing complications. This may include:

  • Blood transfusion - To increase the number of healthy red blood cells in the body.
  • Splenectomy - Surgical removal of the spleen, which can improve anemia in some cases.
  • Antibiotics - To prevent or treat infections.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.